To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
Team Leader: Dr Michel Bottlaender
The Neurology - NeuroPharmacology Team consists mainly of physicians and pharmacists who aim to improve the understanding of normal brain aging and the pathophysiology of neurodegenerative diseases.In clew of that, we aim to develop new imaging biomarkers based on the use of new multi-modal Neuro Imaging tools. These tools are implemented during clinical research protocols.For that we collaborate closely with the methodological experts of the Frédéric Joliot Institute and the Teams of specialized clinicians of the Parisian hospitals.We are particularly interested in anatomical changes, connectivity and tissues microstructure involvement in cortical dementia including Alzheimer's disease, vascular dementia, Parkinson's disease, and multiple sclerosis.
Michel Bottlaender (médecin)Jean-Robert Deverre (Pharmacien)Aicha Lyoubi Idrissi (Neurologue en interface)Lorraine Hamelin (Neurologue en thèse de Science)
P Brugière (NeuroRadiologue , CHU de Creteil)H Chabriat – E Jouvent (Neurologues, CHU Lariboisière, Paris)C Delmaire (NeuroRadiologue, CHU de Lille)M Sarazin (Neurologue, Hopital Sainte Anne, Paris)B Stankoff (Neurologue, CHU Saint Antoine, Paris)
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.